ライフサイエンスコーパス: thyroidectomy

1 oactive iodine (RAI), or surgery (near-total thyroidectomy).

2 oid carcinoma five or more years after total thyroidectomy.

3 The fifth lesion was found to be benign at thyroidectomy.

4 ion characteristic of MEN-2A underwent total thyroidectomy.

5 All patients had undergone total thyroidectomy.

6 Each patient previously had a near-total thyroidectomy.

7 sts before, 1 week after, and 3 months after thyroidectomy.

8 tients, who then underwent a one-stage total thyroidectomy.

9 gnosis is often still established only after thyroidectomy.

10 ersistently elevated calcitonin levels after thyroidectomy.

11 ar extension) showed no benefit over partial thyroidectomy.

12 th complication rates and length of stay for thyroidectomy.

13 rathyroidism is a recognized complication of thyroidectomy.

14 and residual activity in the neck following thyroidectomy.

15 oid glands resected or devascularized during thyroidectomy.

16 enetic testing are candidates for preventive thyroidectomy.

17 tracked for 6 or more months after oncologic thyroidectomy.

18 oblem that commonly occurs in patients after thyroidectomy.

19 es treatment with antithyroid drugs, RAI, or thyroidectomy.

20 mical measure to reduce PONV incidence after thyroidectomy.

21 roidectomy, and 3 patients received subtotal thyroidectomy.

22 e should be an absolute indication for total thyroidectomy.

23 e of undiagnosed cancer requiring completion thyroidectomy.

24 versial and ranges from observation to total thyroidectomy.

25 Use of radioactive iodine after total thyroidectomy.

26 e of the most common complications following thyroidectomy.

27 4 cm should be considered for initial total thyroidectomy.

28 having either total, subtotal, or completion thyroidectomy, 104 (54%) experienced a [Ca(+2)]nadir les

29 gastrectomy (54%), pancreatectomy (31%), and thyroidectomy (23%).

30 A 67-yr-old woman who underwent total thyroidectomy 32 yr ago developed accelerated hyperthyro

31 Among 16,954 patients undergoing total thyroidectomy, 47% had thyroid cancer and 53% benign dis

32 Among 16,954 patients undergoing total thyroidectomy, 47% had thyroid cancer and 53% benign dis

33 patient group was 82% in patients with total thyroidectomy, 78% in patients with subtotal thyroidecto

34 ly, in tumor burden or stage, or in the post-thyroidectomy ablation rate (group 1, 81%; group 2, 74%;

35 onwide inpatient sample was used to identify thyroidectomy admissions from 1999 to 2004, using ICD-9

36 ble analysis, compared with those undergoing thyroidectomy alone, RAI treatment was associated with a

37 justment for potential confounders, surgical thyroidectomy, alone or in combination with medical ther

38 ) performed the greatest proportion of total thyroidectomies among the 5860 discharges, and they were

39 ases of permanent hypoparathyroidism per 100 thyroidectomies and 0.99 to 2.13 cases of recurrent lary

40 ferentiated thyroid cancer who had undergone thyroidectomy and ( 131)I ablation, posttherapy ( 131)I

41 61,775 PTC patients, 54,926 underwent total thyroidectomy and 6849 lobectomy.

42 Total thyroidectomy and central neck dissection followed by ra

43 tation informs the age at which prophylactic thyroidectomy and diagnostic screening for MEN-associate

44 ment, and a malignant nodule, which requires thyroidectomy and further treatment.

45 based on whether they had undergone previous thyroidectomy and on the results of standardized staging

46 toperative management in most patients after thyroidectomy and parathyroid autotransplantation involv

47 Children undergoing thyroidectomy and parathyroidectomy have higher complica

48 Complications following thyroidectomy and parathyroidectomy in children can have

49 cioeconomic disparities in adults undergoing thyroidectomy and parathyroidectomy.

50 Early vocal symptoms are common following thyroidectomy and persist in 14% of patients.

51 After thyroidectomy and radioiodine ablation, thyroglobulin be

52 itial treatments: 46 patients received total thyroidectomy and RAI, 3 patients received total thyroid

53 tal of 116 patients with PTC underwent total thyroidectomy and routine prophylactic CND at a tertiary

54 Patients who underwent thyroidectomy and sentinel lymph node biopsy for papilla

55 An analysis of 194 patients having thyroidectomy and simultaneous parathyroid autotransplan

56 ctive studies can confirm our finding that a thyroidectomy and statin use are associated with substan

57 induced to express 100% beta-MHC by surgical thyroidectomy and subsequent treatment with propylthiour

58 ersistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the ce

59 therapy, patients are first treated by total thyroidectomy and then allowed to become hypothyroid.

60 nsive lymphadenectomy at the time of initial thyroidectomy and to consider reoperative cervical lymph

61 Because one patient had undergone total thyroidectomy and was excluded from the study, a retrosp

62 ent of patients who have not had an adequate thyroidectomy and who are poor candidates for reoperatio

63 tly used therapies--antithyroid medications, thyroidectomy, and (131)I treatment--are presented.

64 oidectomy and RAI, 3 patients received total thyroidectomy, and 3 patients received subtotal thyroide

65 thyroidectomy, 78% in patients with subtotal thyroidectomy, and 89% in patients with lobectomy (p = 0

66 173 patients, 43,227 (82.9%) underwent total thyroidectomy, and 8946 (17.1%) underwent lobectomy.

67 greater than 45 y, the female sex, subtotal thyroidectomy, and RAI-avid diffuse bilateral pulmonary

68 Hypothyroidism was achieved by thyroidectomy, and the 'intruder' stress was used as a m

69 cular thyroid tumors could avert over 14,000 thyroidectomies annually in the United States, thereby s

70 ients who carry this mutation can be offered thyroidectomy at a very young age, hopefully at a point

71 ished that strengthen the argument for total thyroidectomy at the time of diagnosis, followed by admi

72 and the present, we performed 102 preventive thyroidectomies attempting to preserve the parathyroid g

73 There are strong proponents for total thyroidectomy based on its presumed and theoretical dise

74 on controversial topics, including extent of thyroidectomy based on tumor size, prophylactic central

75 fine needle aspiration (FNA) biopsy require thyroidectomy because of a 20% to 30% risk of thyroid ca

76 rent disease in children who underwent total thyroidectomy before eight years of age and in children

77 no previous surgery; group 2 (13) underwent thyroidectomy before referral and had an elevated calcit

78 stant metastases; and group 3 (16) underwent thyroidectomy before referral and had an elevated calcit

79 hospital with thyroid cancer and underwent a thyroidectomy between 2001 and 2011 in Massachusetts (n

80 (N = 671) with nonmalignant cytology who had thyroidectomy between October 2010 and March 2012, cytol

81 rgeons (>100 cases per year) performed 5% of thyroidectomies, but 90% of their patients were white (P

82 esda criteria, and 1 or more indications for thyroidectomy by 2009 American Thyroid Association guide

83 d superior laryngeal nerve injury during her thyroidectomy by Arnold Kegel, MD, in 1935, resulting in

84 Thyroidectomy caused a 25% reduction in olfactory GST al

85 e internal jugular vein (IJV) after subtotal thyroidectomy caused by local recurrence of papillary th

86 f the parathyroids in situ during preventive thyroidectomy combined with selective CND based on preop

87 e a survival advantage associated with total thyroidectomy compared with lobectomy.

88 esophagectomy, gastrectomy, pancreatectomy, thyroidectomy, coronary artery bypass graft surgery, and

89 dies have indicated that total or near-total thyroidectomy decreases overall recurrence rate.

90 Twenty-five thyroidectomy explorations in 15 patients were monitored

91 After total thyroidectomy followed by radioiodine ablation, 61 conse

92 ng surveillance for recurrent disease, total thyroidectomy followed by RAI appears to be the most ben

93 Patients undergoing thyroidectomy for benign disease were allocated by a blo

94 The extent of primary thyroidectomy for differentiated thyroid cancer is contr

95 nt ablation (RRA) is frequently used after a thyroidectomy for differentiated thyroid carcinoma becau

96 indings involving 166 patients who underwent thyroidectomy for differentiated thyroid carcinoma was p

97 o received outpatient 131I therapy following thyroidectomy for differentiated thyroid carcinoma were

98 Following thyroidectomy for differentiated thyroid carcinoma, 50 p

99 previously had undergone total or near-total thyroidectomy for differentiated thyroid carcinoma.

100 or radioablation of thyroid remnants after a thyroidectomy for differentiated thyroid carcinoma.

101 eria were an age of 18 years or older; total thyroidectomy for differentiated thyroid carcinoma; tumo

102 18 to 65 years who were scheduled for total thyroidectomy for goiter, benign nodular disease, suspec

103 Most experienced surgeons recommend total thyroidectomy for Hurthle cell carcinomas and reserve th

104 A rising calcitonin level after total thyroidectomy for localized disease generally indicates

105 e parathyroid glands resected at the time of thyroidectomy for medullary thyroid carcinoma and transp

106 Seventy-three patients underwent thyroidectomy for palpable MTC with immediate or delayed

107 Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcin

108 Many patients undergoing thyroidectomy for papillary thyroid carcinoma (PTC) have

109 used to better define the optimal extent of thyroidectomy for patients with thyroid cancer.

110 Consensus guidelines have recommended total thyroidectomy for PTC > or =1 cm; however, no study has

111 is the first study to demonstrate that total thyroidectomy for PTC > or =1.0 cm improves outcomes.

112 Guidelines recommend total thyroidectomy for PTC tumors >1 cm, based on older data

113 Current guidelines suggest total thyroidectomy for PTC tumors >1 cm.

114 tive series of 1510 patients who had initial thyroidectomy for TC with routine testing for BRAF, RAS,

115 hyroid carcinoma and performing prophylactic thyroidectomy for the prevention or cure of this disease

116 was associated with a 26% increased rate of thyroidectomy for treating thyroid cancer.

117 ns were obtained from 29 women who underwent thyroidectomy for various thyroid disorders.

118 oid glands resected or devascularized during thyroidectomy for well-differentiated thyroid carcinoma

119 All records of thyroidectomies from the First Affiliated Hospital of Na

120 ed with lobectomy, patients undergoing total thyroidectomy had more nodal (7% vs 27%), extrathyroidal

121 The authors have addressed whether total thyroidectomy has a survival benefit justifying its use

122 outcome association has been established for thyroidectomy; however, a threshold number of cases defi

123 outcome association has been established for thyroidectomy; however, a threshold number of cases defi

124 Total or near-total thyroidectomy improved overall survival (risk ratio [RR]

125 on form of thyroid carcinoma detected during thyroidectomies in China while other features of thyroid

126 s performed in 56 patients, near or subtotal thyroidectomy in 47 patients and lobectomy in 55 patient

127 An incidental cancer was found at thyroidectomy in a nonvisualized nodule.

128 We sought to determine whether total thyroidectomy in asymptomatic young members of kindreds

129 Prophylactic thyroidectomy in hereditary cases of MTMC may be guided

130 Total thyroidectomy in high-risk patients with differentiated

131 ional analysis of all patients who underwent thyroidectomy in Maryland between 1991 and 1996 was cond

132 ed by the increased use of total or subtotal thyroidectomy in patients with advanced disease.

133 t survival difference according to extent of thyroidectomy in the intermediate or high-risk groups ei

134 tients with PTC tumors 1.0-4.0 cm undergoing thyroidectomy in the National Cancer Database, 1998-2006

135 ed with a 26% increased rate of undergoing a thyroidectomy (incident rate ratio, 1.26; 95% CI, 1.04-1

136 Thyroid disease is common, and thyroidectomy is a mainstay of treatment for many benign

137 Total thyroidectomy is an option in selected cases.

138 ify a tumor size threshold above which total thyroidectomy is associated with an improvement in recur

139 Overall, thyroidectomy is associated with favorable outcomes, par

140 eshold could be identified above which total thyroidectomy is associated with improved outcomes.

141 Determining the correct extent of initial thyroidectomy is challenging.

142 These findings suggest that, although thyroidectomy is considered safe, significant racial dis

143 Management of the parathyroids during thyroidectomy is controversial.

144 Thyroidectomy is effective and is the only measure that

145 or targeted molecular therapies.Prophylactic thyroidectomy is indicated early in life for RET mutatio

146 This suggests that the general use of total thyroidectomy is not indicated, except in highly selecte

147 and the circumstances in which prophylactic thyroidectomy is reasonable to consider as part of hered

148 d (131)I(-) treatment of thyroid cancer post-thyroidectomy is the most effective targeted internal ra

149 Total or near-total thyroidectomy is the treatment of choice in patients wit

150 lead to increased AF vulnerability in a rat thyroidectomy model.

151 I uptake and MPA for initial treatment after thyroidectomy (n = 39), including 17 patients with compr

152 After total thyroidectomy, no patient in either group developed perm

153 tween 1993 and 2000, we performed preventive thyroidectomies on 50 patients with MEN2A (group A).

154 PTU treatment, T(4) replacement therapy and thyroidectomy on GST expression, GST and glutathione per

155 ity was manipulated by surgical and chemical thyroidectomy on the one hand, and by thyroxine (T(4)) a

156 garding patient demographics, indication for thyroidectomy, operative procedure, pathologic diagnoses

157 mulating hormone (TSH) elevation after total thyroidectomy or after discontinuation of thyroxine (T(4

158 f FNA specimens may help to avoid diagnostic thyroidectomy or may help in deciding the extent of surg

159 Surgeons were categorized by volume of thyroidectomies over the 6-year study period: A (1 to 9

160 Surgeons who recommend total thyroidectomy over lobectomy for subcentimeter unifocal

161 ting an overall survival advantage for total thyroidectomy over lobectomy.

162 ia was more frequent after total or subtotal thyroidectomy (p = 0.001) while wound complications incr

163 One hundred twenty-two consecutive post-thyroidectomy patients for differentiated thyroid carcin

164 al protocol for imaging and ablation of post-thyroidectomy patients.

165 Following thyroidectomy, patients were prescribed LT4.

166 sociation between the number of annual total thyroidectomies per surgeon and risk of complications.

167 sociation between the number of annual total thyroidectomies per surgeon and risk of complications.

168 OBJECTIVE:: To determine the number of total thyroidectomies per surgeon per year associated with the

169 To determine the number of total thyroidectomies per surgeon per year associated with the

170 te a more complete operative plan, including thyroidectomy, possible lymphadenectomy, and postoperati

171 nch of the vagus nerve may be injured during thyroidectomy, producing vocal defects more subtle than

172 Change in the thyroidectomy rate for thyroid cancer treatment was the

173 t-subsidized or self-pay insurance had lower thyroidectomy rates for thyroid cancer in Massachusetts

174 Does dexamethasone given before thyroidectomy reduce postoperative nausea and vomiting (

175 Even though conventional thyroidectomy remains in the gold standard for thyroidec

176 Thyroidectomy remains the mainstay of treatment for thyr

177 ic efficacy of (131)I given to ablate a post-thyroidectomy remnant.

178 results of this study demonstrate that total thyroidectomy results in lower recurrence rates and impr

179 ients with MEN2A treated by preventive total thyroidectomy routine total parathyroidectomy with autot

180 ll localized lesions while total or subtotal thyroidectomy should be considered for more extensive tu

181 in complication rates, near-total and total thyroidectomy should be offered to patients with well-di

182 Total thyroidectomy should be used in gene carriers without cl

183 esearchers advocate partial and others total thyroidectomy; some advocate prophylactic central cervic

184 ular carcinoma of the thyroid received total thyroidectomy; this was followed by thyroid hormone with

185 d RET allele, can be managed by prophylactic thyroidectomy, thus preventing the development of medull

186 oidism was induced in adult rats by surgical thyroidectomy; thyroid status was manipulated in culture

187 The mean interval from initial thyroidectomy to palliative surgery was 5.8 +/- 1.5 year

188 laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyro

189 3), but not cortisol, was prevented by fetal thyroidectomy (TX).

190 of functioning residual thyroid tissue after thyroidectomy using radioiodine whole-body (WB) imaging

191 val was similar in patients undergoing total thyroidectomy versus lobectomy for tumors 1.0-4.0 cm [ha

192 utine parathyroid autotransplantation during thyroidectomy virtually eliminates postoperative hypopar

193 The natural history of post-thyroidectomy voice disturbances for patients with prese

194 laryngeal nerve injury appear to alter post-thyroidectomy voice.

195 treated with radioactive iodine after total thyroidectomy was assessed with multivariable weighted r

196 Total or near-total thyroidectomy was done in 85.3% of patients with papilla

197 ypocalcemia increased when total or subtotal thyroidectomy was done.

198 Total thyroidectomy was performed in 56 patients, near or subt

199 Adults undergoing total thyroidectomy were identified from the Health Care Utili

200 Adults undergoing total thyroidectomy were identified from the Health Care Utili

201 tients who had undergone near-total or total thyroidectomy, which suggests that T3 administration is

202 Total thyroidectomy with 'therapeutic' cervical lymph node dis

203 ent studies performed on patients undergoing thyroidectomy with coexisting Hashimoto's thyroiditis re

204 equally strong advocates of less aggressive thyroidectomy with its lower hazard of parathyroid and r

205 Therefore, total thyroidectomy with left neck dissection and segmental re

206 yroidectomy remains in the gold standard for thyroidectomy with low morbidity and excellent outcomes,

207 1-cm papillary thyroid cancer who underwent thyroidectomy with one or more lymph nodes (LNs) examine

208 lary thyroid carcinoma, near-total and total thyroidectomy with routine central and bilateral functio

209 entify a surgeon volume threshold (>25 total thyroidectomies/y) that is associated with improved pati

210 entify a surgeon volume threshold (>25 total thyroidectomies/y) that is associated with improved pati